25 XP   0   0   10

Bicycle Therapeutics Ltd
Buy, Hold or Sell?

Let's analyse Bicycle Therapeutics Ltd together

PenkeI guess you are interested in Bicycle Therapeutics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bicycle Therapeutics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bicycle Therapeutics Ltd

I send you an email if I find something interesting about Bicycle Therapeutics Ltd.

Quick analysis of Bicycle Therapeutics Ltd (30 sec.)










What can you expect buying and holding a share of Bicycle Therapeutics Ltd? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$8.74
Expected worth in 1 year
$10.34
How sure are you?
32.0%

+ What do you gain per year?

Total Gains per Share
$1.60
Return On Investment
6.5%

For what price can you sell your share?

Current Price per Share
$24.55
Expected price per share
$22.49 - $28.91
How sure are you?
50%

1. Valuation of Bicycle Therapeutics Ltd (5 min.)




Live pricePrice per Share (EOD)

$24.55

Intrinsic Value Per Share

$-42.89 - $-50.98

Total Value Per Share

$-34.14 - $-42.23

2. Growth of Bicycle Therapeutics Ltd (5 min.)




Is Bicycle Therapeutics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$370.9m$300.4m$12m3.9%

How much money is Bicycle Therapeutics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$45.1m-$28.1m-$16.9m-37.6%
Net Profit Margin-756.3%-800.1%--

How much money comes from the company's main activities?

3. Financial Health of Bicycle Therapeutics Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#150 / 1031

Most Revenue
#324 / 1031

Most Profit
#905 / 1031

Most Efficient
#796 / 1031

What can you expect buying and holding a share of Bicycle Therapeutics Ltd? (5 min.)

Welcome investor! Bicycle Therapeutics Ltd's management wants to use your money to grow the business. In return you get a share of Bicycle Therapeutics Ltd.

What can you expect buying and holding a share of Bicycle Therapeutics Ltd?

First you should know what it really means to hold a share of Bicycle Therapeutics Ltd. And how you can make/lose money.

Speculation

The Price per Share of Bicycle Therapeutics Ltd is $24.55. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bicycle Therapeutics Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bicycle Therapeutics Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $8.74. Based on the TTM, the Book Value Change Per Share is $0.40 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.50 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bicycle Therapeutics Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.16-4.7%-1.17-4.8%-0.74-3.0%-0.58-2.4%-0.49-2.0%
Usd Book Value Change Per Share-1.77-7.2%0.401.6%-0.50-2.0%0.532.2%0.351.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.77-7.2%0.401.6%-0.50-2.0%0.532.2%0.351.4%
Usd Price Per Share18.08-21.24-28.38-22.92-18.34-
Price to Earnings Ratio-3.91--4.57--9.53--12.05--9.64-
Price-to-Total Gains Ratio-10.23--19.26--59.45--1,505.76--1,505.76-
Price to Book Ratio2.07-2.92-3.56-4.92-3.93-
Price-to-Total Gains Ratio-10.23--19.26--59.45--1,505.76--1,505.76-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share24.55
Number of shares40
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.400.53
Usd Total Gains Per Share0.400.53
Gains per Quarter (40 shares)15.9621.18
Gains per Year (40 shares)63.8484.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10645408575
201281180169160
301921820254245
402552460339330
503193100424415
603833740508500
704474380593585
805115020678670
905755660762755
1006386300847840

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.025.00.00.0%0.025.00.00.0%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%7.013.00.035.0%8.014.03.032.0%8.014.03.032.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.025.00.0%0.00.025.00.0%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%7.013.00.035.0%8.014.03.032.0%8.014.03.032.0%

Fundamentals of Bicycle Therapeutics Ltd

About Bicycle Therapeutics Ltd

Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. Its product pipeline comprising BT8009, a bicycle toxin conjugate (BTC) which is in phase I/II and phase II/III clinical trial for the treatment of high nectin-4 expressing tumors; BT5528, a BTC which is in phase I/II clinical trial for the treatment of Ephrin type A receptor 2 expressing tumor; BT7480, a Bicycle TICA molecule which is in phase I/II targeting Nectin-4 and agonizing CD137; and BT7455, a Bicycle TICA molecule targeting Ephrin type A receptor 2 and CD137 and is in preclinical trial. The company also developing BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease; and BT7401, a multivalent bicycle CD137 agonist which is in phase IIa to treat advanced solid tumors. In addition, it develops Novel anti-infective, which is in preclinical trial targeting anti-infectives disease; CNS targets, which is in preclinical trial targeting CNS disease; and Novel neuromuscular targets, which is in preclinical trial targeting neuromuscular disease. Further, the company collaborates with biopharmaceutical companies and organizations to develop programs in therapeutic areas. The company has collaboration and license agreement with Bayer Consumer Care AG; Novartis Pharma AG; Cancer Research UK; Cancer Research Technology Ltd; and Oxurion NV. Bicycle Therapeutics plc was incorporated in 2009 and is headquartered in Cambridge, the United Kingdom.

Fundamental data was last updated by Penke on 2024-03-20 11:16:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Bicycle Therapeutics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bicycle Therapeutics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bicycle Therapeutics Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -921.0% means that $-9.21 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bicycle Therapeutics Ltd:

  • The MRQ is -921.0%. The company is making a huge loss. -2
  • The TTM is -756.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-921.0%TTM-756.3%-164.8%
TTM-756.3%YOY-800.1%+43.9%
TTM-756.3%5Y-691.7%-64.6%
5Y-691.7%10Y-648.8%-42.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-921.0%-171.8%-749.2%
TTM-756.3%-205.8%-550.5%
YOY-800.1%-262.1%-538.0%
5Y-691.7%-455.6%-236.1%
10Y-648.8%-589.0%-59.8%
1.1.2. Return on Assets

Shows how efficient Bicycle Therapeutics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bicycle Therapeutics Ltd to the Biotechnology industry mean.
  • -8.2% Return on Assets means that Bicycle Therapeutics Ltd generated $-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bicycle Therapeutics Ltd:

  • The MRQ is -8.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.2%TTM-8.6%+0.4%
TTM-8.6%YOY-6.5%-2.1%
TTM-8.6%5Y-7.5%-1.2%
5Y-7.5%10Y-7.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.2%-12.5%+4.3%
TTM-8.6%-12.2%+3.6%
YOY-6.5%-11.2%+4.7%
5Y-7.5%-13.4%+5.9%
10Y-7.4%-14.7%+7.3%
1.1.3. Return on Equity

Shows how efficient Bicycle Therapeutics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bicycle Therapeutics Ltd to the Biotechnology industry mean.
  • -13.2% Return on Equity means Bicycle Therapeutics Ltd generated $-0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bicycle Therapeutics Ltd:

  • The MRQ is -13.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.2%TTM-15.2%+1.9%
TTM-15.2%YOY-9.5%-5.7%
TTM-15.2%5Y-11.5%-3.6%
5Y-11.5%10Y-9.2%-2.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.2%-15.8%+2.6%
TTM-15.2%-15.7%+0.5%
YOY-9.5%-13.9%+4.4%
5Y-11.5%-18.3%+6.8%
10Y-9.2%-19.2%+10.0%

1.2. Operating Efficiency of Bicycle Therapeutics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bicycle Therapeutics Ltd is operating .

  • Measures how much profit Bicycle Therapeutics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bicycle Therapeutics Ltd to the Biotechnology industry mean.
  • An Operating Margin of -903.1% means the company generated $-9.03  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bicycle Therapeutics Ltd:

  • The MRQ is -903.1%. The company is operating very inefficient. -2
  • The TTM is -748.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-903.1%TTM-748.2%-154.9%
TTM-748.2%YOY-830.8%+82.6%
TTM-748.2%5Y-694.6%-53.6%
5Y-694.6%10Y-652.9%-41.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-903.1%-299.1%-604.0%
TTM-748.2%-210.1%-538.1%
YOY-830.8%-279.7%-551.1%
5Y-694.6%-459.9%-234.7%
10Y-652.9%-596.9%-56.0%
1.2.2. Operating Ratio

Measures how efficient Bicycle Therapeutics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 11.52 means that the operating costs are $11.52 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bicycle Therapeutics Ltd:

  • The MRQ is 11.521. The company is inefficient in keeping operating costs low. -1
  • The TTM is 9.253. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ11.521TTM9.253+2.267
TTM9.253YOY11.188-1.934
TTM9.2535Y9.288-0.035
5Y9.28810Y9.274+0.014
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.5212.861+8.660
TTM9.2533.193+6.060
YOY11.1883.615+7.573
5Y9.2885.560+3.728
10Y9.2747.396+1.878

1.3. Liquidity of Bicycle Therapeutics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bicycle Therapeutics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.08 means the company has $8.08 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bicycle Therapeutics Ltd:

  • The MRQ is 8.080. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.393. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.080TTM7.393+0.687
TTM7.393YOY9.529-2.136
TTM7.3935Y9.253-1.860
5Y9.25310Y8.049+1.204
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.0803.986+4.094
TTM7.3934.440+2.953
YOY9.5295.552+3.977
5Y9.2536.158+3.095
10Y8.0496.492+1.557
1.3.2. Quick Ratio

Measures if Bicycle Therapeutics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bicycle Therapeutics Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 7.92 means the company can pay off $7.92 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bicycle Therapeutics Ltd:

  • The MRQ is 7.916. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.217. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.916TTM7.217+0.699
TTM7.217YOY9.315-2.098
TTM7.2175Y9.005-1.788
5Y9.00510Y7.551+1.454
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.9163.638+4.278
TTM7.2174.168+3.049
YOY9.3155.515+3.800
5Y9.0056.012+2.993
10Y7.5516.209+1.342

1.4. Solvency of Bicycle Therapeutics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bicycle Therapeutics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bicycle Therapeutics Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.38 means that Bicycle Therapeutics Ltd assets are financed with 37.7% credit (debt) and the remaining percentage (100% - 37.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bicycle Therapeutics Ltd:

  • The MRQ is 0.377. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.418. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.377TTM0.418-0.042
TTM0.418YOY0.307+0.111
TTM0.4185Y0.331+0.088
5Y0.33110Y0.392-0.062
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3770.335+0.042
TTM0.4180.330+0.088
YOY0.3070.267+0.040
5Y0.3310.367-0.036
10Y0.3920.378+0.014
1.4.2. Debt to Equity Ratio

Measures if Bicycle Therapeutics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bicycle Therapeutics Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 60.5% means that company has $0.60 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bicycle Therapeutics Ltd:

  • The MRQ is 0.605. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.742. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.605TTM0.742-0.137
TTM0.742YOY0.445+0.297
TTM0.7425Y0.521+0.221
5Y0.52110Y0.416+0.104
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6050.376+0.229
TTM0.7420.398+0.344
YOY0.4450.334+0.111
5Y0.5210.429+0.092
10Y0.4160.476-0.060

2. Market Valuation of Bicycle Therapeutics Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bicycle Therapeutics Ltd generates.

  • Above 15 is considered overpriced but always compare Bicycle Therapeutics Ltd to the Biotechnology industry mean.
  • A PE ratio of -3.91 means the investor is paying $-3.91 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bicycle Therapeutics Ltd:

  • The EOD is -5.303. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.905. Based on the earnings, the company is expensive. -2
  • The TTM is -4.572. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.303MRQ-3.905-1.397
MRQ-3.905TTM-4.572+0.667
TTM-4.572YOY-9.530+4.958
TTM-4.5725Y-12.048+7.475
5Y-12.04810Y-9.638-2.410
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.303-2.643-2.660
MRQ-3.905-2.418-1.487
TTM-4.572-2.742-1.830
YOY-9.530-4.123-5.407
5Y-12.048-6.257-5.791
10Y-9.638-6.478-3.160
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bicycle Therapeutics Ltd:

  • The EOD is -5.500. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.050. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -32.807. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.500MRQ-4.050-1.449
MRQ-4.050TTM-32.807+28.757
TTM-32.807YOY-12.952-19.855
TTM-32.8075Y-16.462-16.345
5Y-16.46210Y-13.170-3.292
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.500-3.244-2.256
MRQ-4.050-2.939-1.111
TTM-32.807-3.478-29.329
YOY-12.952-5.592-7.360
5Y-16.462-8.473-7.989
10Y-13.170-8.881-4.289
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bicycle Therapeutics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.07 means the investor is paying $2.07 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bicycle Therapeutics Ltd:

  • The EOD is 2.808. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.068. Based on the equity, the company is underpriced. +1
  • The TTM is 2.921. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.808MRQ2.068+0.740
MRQ2.068TTM2.921-0.854
TTM2.921YOY3.565-0.644
TTM2.9215Y4.916-1.995
5Y4.91610Y3.933+0.983
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.8082.124+0.684
MRQ2.0682.041+0.027
TTM2.9212.118+0.803
YOY3.5652.915+0.650
5Y4.9163.682+1.234
10Y3.9334.114-0.181
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bicycle Therapeutics Ltd.

3.1. Institutions holding Bicycle Therapeutics Ltd

Institutions are holding 91.988% of the shares of Bicycle Therapeutics Ltd.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Paradigm Biocapital Advisors LP9.78613.13793707001646941.7762
2023-12-31Deep Track Capital, LP9.21462.1076349050600
2023-12-31Jefferies Financial Group Inc5.14250.2297194800000
2023-12-31Baker Bros Advisors LP4.72640.36831790390946576112.1783
2023-12-31Tybourne Capital Management (HK) Ltd4.35674.4457165032036850028.7482
2023-12-31First Light Asset Management, LLC4.09312.25531550471-520382-25.1289
2023-12-31Armistice Capital, LLC4.05490.3791153600053600053.6
2023-09-30Point72 Asset Management, L.P.3.43050.07621299500821500171.8619
2023-09-30BRAIDWELL LP3.40510.8189128987212898720
2023-12-31Morgan Stanley - Brokerage Accounts2.7170.00161029225-592524-36.5361
2023-12-31Polar Capital Holdings PLC2.65190.11131004535-6965-0.6886
2023-12-31Westfield Capital Management Company, LP2.42160.09679173049173040
2023-12-31Suvretta Capital Management, LLC2.41410.7475914476-96500-9.5452
2023-12-31Candriam Luxembourg S.C.A.2.29470.1085869258-384003-30.6403
2023-12-31RA Capital Management, LLC2.11190.225980000000
2023-12-31BNP Paribas Investment Partners SA2.0670.039478299814211622.1751
2023-12-31Verition Fund Managegment, LLC1.95490.1048740539-175843-19.1888
2023-12-31AXA SA1.46270.0323554086-20981-3.6484
2023-12-31BlackRock Inc1.32420.0002501623307539158.4566
2023-12-31Bank of America Corp1.21790.00084613314550357227.3666
Total 70.847815.287726837435+4051938+15.1%

3.2. Funds holding Bicycle Therapeutics Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Polar Capital Biotech S Inc2.63991.0724100000000
2024-01-31BNP Paribas Health Cr Innovtr Cl Cap1.5840.6182600020-1299-0.216
2023-12-31Candriam Global Equities Oncology1.53360.5657580934-187000-24.3511
2024-02-29Belfius Equities Cure C Cap1.46760.738455593400
2023-12-31Westfield Capital Mgt Co Sm-Cap Gr Eq1.04030.56763940503940500
2023-12-31Harbor Small Cap Growth Instl1.04030.56753940503940500
2024-01-31BlackRock Health Sciences Term Trust0.73460.257827827000
2024-01-31AXA Framlington Health Fund - R Income0.72330.644627398300
2024-01-31Candriam Eqs L Biotech C USD Cap0.72150.2904273295-15000-5.203
2024-01-31UTM IM GBP AXA Framlington Biotech0.70940.875826872400
2024-01-31BNP Paribas US Small Cap Classic R0.60950.53622308864809726.3129
2024-02-29iShares Biotechnology ETF0.54140.0677205100-925-0.449
2023-12-31T. Rowe Price Health Sciences0.53190.0248201468-257548-56.1087
2024-02-29Handelsbanken Hälsovård Tema (A1 SEK)0.44880.21351700004000030.7692
2023-12-31Kennedy Small Cap Growth0.37190.51531408904701050.0746
2023-11-30MEDICAL BioHealth EUR Acc0.36310.291613753000
2023-12-31Kennedy Micro Cap0.36290.52431374541374540
2024-01-31Fidelity Select Biotechnology0.280.0401106047-160300-60.1846
2024-01-31Allianz Biotechnologie P EUR0.26350.48159982000
2023-12-31AlphaCentric LifeSci Healthcare I0.23761.5611900003150053.8462
Total 16.205110.45456138455+470089+7.7%

3.3. Insider Transactions

Insiders are holding 6.197% of the shares of Bicycle Therapeutics Ltd.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-03Kevin LeeSELL870317.5
2024-01-03Nigel CrockettSELL264317.5
2024-01-03Travis Alvin ThompsonSELL60417.5
2023-10-03Alistair MilnesSELL44220
2023-10-03Kevin LeeSELL147020
2023-10-03Nicholas KeenSELL27220
2023-10-03Travis Alvin ThompsonSELL5420
2023-07-03Kevin LeeSELL149825.1
2023-07-03Michael SkynnerSELL45125.1
2023-07-03Nicholas KeenSELL33625.1
2023-07-03Travis Alvin ThompsonSELL6125.1
2023-04-03Kevin LeeSELL148621.11
2023-04-03Lee KalowskiSELL37621.11
2023-04-03Michael SkynnerSELL44721.11
2023-04-03Nicholas KeenSELL31921.11

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Bicycle Therapeutics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.7670.399-543%-0.498-72%0.529-434%0.350-605%
Book Value Per Share--8.7447.871+11%7.932+10%5.153+70%4.256+105%
Current Ratio--8.0807.393+9%9.529-15%9.253-13%8.049+0%
Debt To Asset Ratio--0.3770.418-10%0.307+23%0.331+14%0.392-4%
Debt To Equity Ratio--0.6050.742-18%0.445+36%0.521+16%0.416+45%
Dividend Per Share----0%-0%-0%-0%
Eps---1.157-1.167+1%-0.744-36%-0.578-50%-0.493-57%
Free Cash Flow Per Share---1.116-0.386-65%-0.694-38%-0.303-73%-0.274-75%
Free Cash Flow To Equity Per Share---1.1071.198-192%-0.649-41%0.606-283%0.541-305%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---50.978--------
Intrinsic Value_10Y_min---42.888--------
Intrinsic Value_1Y_max---2.100--------
Intrinsic Value_1Y_min---2.061--------
Intrinsic Value_3Y_max---8.602--------
Intrinsic Value_3Y_min---8.166--------
Intrinsic Value_5Y_max---17.868--------
Intrinsic Value_5Y_min---16.387--------
Market Cap929961365.000+18%766941414.080833612968.278-8%1075042914.000-29%874099315.856-12%699279452.684+10%
Net Profit Margin---9.210-7.563-18%-8.001-13%-6.917-25%-6.488-30%
Operating Margin---9.031-7.482-17%-8.308-8%-6.946-23%-6.529-28%
Operating Ratio--11.5219.253+25%11.188+3%9.288+24%9.274+24%
Pb Ratio2.808+26%2.0682.921-29%3.565-42%4.916-58%3.933-47%
Pe Ratio-5.303-36%-3.905-4.572+17%-9.530+144%-12.048+209%-9.638+147%
Price Per Share24.550+26%18.08021.240-15%28.380-36%22.922-21%18.338-1%
Price To Free Cash Flow Ratio-5.500-36%-4.050-32.807+710%-12.952+220%-16.462+306%-13.170+225%
Price To Total Gains Ratio-13.890-36%-10.229-19.260+88%-59.448+481%-1505.761+14620%-1505.761+14620%
Quick Ratio--7.9167.217+10%9.315-15%9.005-12%7.551+5%
Return On Assets---0.082-0.086+5%-0.065-21%-0.075-10%-0.074-10%
Return On Equity---0.132-0.152+15%-0.095-29%-0.115-13%-0.092-30%
Total Gains Per Share---1.7670.399-543%-0.498-72%0.529-434%0.350-605%
Usd Book Value--370932000.000312553500.000+19%300476750.000+23%198059300.000+87%163535520.000+127%
Usd Book Value Change Per Share---1.7670.399-543%-0.498-72%0.529-434%0.350-605%
Usd Book Value Per Share--8.7447.871+11%7.932+10%5.153+70%4.256+105%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.157-1.167+1%-0.744-36%-0.578-50%-0.493-57%
Usd Free Cash Flow---47339000.000-15889250.000-66%-26274500.000-44%-11731800.000-75%-10565720.000-78%
Usd Free Cash Flow Per Share---1.116-0.386-65%-0.694-38%-0.303-73%-0.274-75%
Usd Free Cash Flow To Equity Per Share---1.1071.198-192%-0.649-41%0.606-283%0.541-305%
Usd Market Cap929961365.000+18%766941414.080833612968.278-8%1075042914.000-29%874099315.856-12%699279452.684+10%
Usd Price Per Share24.550+26%18.08021.240-15%28.380-36%22.922-21%18.338-1%
Usd Profit---49099000.000-45166000.000-8%-28179250.000-43%-22090900.000-55%-18779560.000-62%
Usd Revenue--5331000.0006744000.000-21%3615750.000+47%3866350.000+38%3404720.000+57%
Usd Total Gains Per Share---1.7670.399-543%-0.498-72%0.529-434%0.350-605%
 EOD+5 -3MRQTTM+14 -19YOY+7 -265Y+7 -2610Y+12 -21

4.2. Fundamental Score

Let's check the fundamental score of Bicycle Therapeutics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.303
Price to Book Ratio (EOD)Between0-12.808
Net Profit Margin (MRQ)Greater than0-9.210
Operating Margin (MRQ)Greater than0-9.031
Quick Ratio (MRQ)Greater than17.916
Current Ratio (MRQ)Greater than18.080
Debt to Asset Ratio (MRQ)Less than10.377
Debt to Equity Ratio (MRQ)Less than10.605
Return on Equity (MRQ)Greater than0.15-0.132
Return on Assets (MRQ)Greater than0.05-0.082
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Bicycle Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.513
Ma 20Greater thanMa 5024.817
Ma 50Greater thanMa 10021.774
Ma 100Greater thanMa 20018.922
OpenGreater thanClose24.660
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets595,344
Total Liabilities224,412
Total Stockholder Equity370,932
 As reported
Total Liabilities 224,412
Total Stockholder Equity+ 370,932
Total Assets = 595,344

Assets

Total Assets595,344
Total Current Assets561,868
Long-term Assets33,476
Total Current Assets
Cash And Cash Equivalents 526,423
Net Receivables 24,039
Other Current Assets 11,406
Total Current Assets  (as reported)561,868
Total Current Assets  (calculated)561,868
+/-0
Long-term Assets
Property Plant Equipment 27,684
Long-term Assets Other 5,245
Long-term Assets  (as reported)33,476
Long-term Assets  (calculated)32,929
+/- 547

Liabilities & Shareholders' Equity

Total Current Liabilities69,537
Long-term Liabilities154,875
Total Stockholder Equity370,932
Total Current Liabilities
Short-term Debt 4,876
Accounts payable 13,050
Other Current Liabilities 26,633
Total Current Liabilities  (as reported)69,537
Total Current Liabilities  (calculated)44,559
+/- 24,978
Long-term Liabilities
Long term Debt 30,698
Capital Lease Obligations 14,258
Long-term Liabilities Other 4,579
Long-term Liabilities  (as reported)154,875
Long-term Liabilities  (calculated)49,535
+/- 105,340
Total Stockholder Equity
Common Stock550
Retained Earnings -511,760
Accumulated Other Comprehensive Income -1,304
Other Stockholders Equity 883,446
Total Stockholder Equity (as reported)370,932
Total Stockholder Equity (calculated)370,932
+/-0
Other
Capital Stock550
Cash and Short Term Investments 526,423
Common Stock Shares Outstanding 42,419
Current Deferred Revenue24,978
Liabilities and Stockholders Equity 595,344
Net Debt -481,467
Net Invested Capital 401,630
Net Working Capital 492,331
Property Plant and Equipment Gross 41,077
Short Long Term Debt Total 44,956



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
> Total Assets 
74,001
0
0
0
81,626
77,801
126,246
116,060
110,194
129,282
118,602
170,059
161,152
223,842
226,048
281,333
479,792
459,563
445,482
417,148
410,609
428,801
454,170
638,683
595,344
595,344638,683454,170428,801410,609417,148445,482459,563479,792281,333226,048223,842161,152170,059118,602129,282110,194116,060126,24677,80181,62600074,001
   > Total Current Assets 
71,512
0
0
0
76,769
69,926
120,452
110,250
104,146
123,390
112,531
164,158
155,723
215,393
217,788
272,872
458,555
429,766
408,493
381,285
369,383
381,253
408,430
603,036
561,868
561,868603,036408,430381,253369,383381,285408,493429,766458,555272,872217,788215,393155,723164,158112,531123,390104,146110,250120,45269,92676,76900071,512
       Cash And Cash Equivalents 
67,663
0
0
0
63,380
59,371
108,536
95,954
92,117
109,637
96,910
149,842
135,990
195,901
198,738
259,524
438,680
407,371
372,769
361,469
339,154
293,815
340,433
572,086
526,423
526,423572,086340,433293,815339,154361,469372,769407,371438,680259,524198,738195,901135,990149,84296,910109,63792,11795,954108,53659,37163,38000067,663
       Net Receivables 
3,001
0
0
0
11,313
8,331
9,895
10,760
7,145
9,505
11,303
8,798
14,633
13,530
14,258
7,704
11,910
13,328
26,270
11,368
21,207
76,512
57,974
17,277
24,039
24,03917,27757,97476,51221,20711,36826,27013,32811,9107,70414,25813,53014,6338,79811,3039,5057,14510,7609,8958,33111,3130003,001
       Other Current Assets 
0
0
0
0
2,076
2,224
2,021
3,536
4,884
4,248
4,318
5,518
5,100
5,962
4,792
5,644
7,965
9,067
9,454
8,448
9,022
10,926
10,023
13,673
11,406
11,40613,67310,02310,9269,0228,4489,4549,0677,9655,6444,7925,9625,1005,5184,3184,2484,8843,5362,0212,2242,0760000
   > Long-term Assets 
0
0
0
0
4,857
7,875
5,794
5,810
6,048
5,892
6,071
5,901
5,429
8,449
8,260
8,461
21,237
29,797
36,989
35,863
41,226
47,548
45,740
35,647
33,476
33,47635,64745,74047,54841,22635,86336,98929,79721,2378,4618,2608,4495,4295,9016,0715,8926,0485,8105,7947,8754,8570000
       Property Plant Equipment 
1,362
0
0
0
1,818
4,389
4,388
4,329
4,348
4,018
3,800
3,498
3,607
6,271
5,881
5,683
17,789
25,599
31,891
29,704
32,768
36,982
33,594
30,196
27,684
27,68430,19633,59436,98232,76829,70431,89125,59917,7895,6835,8816,2713,6073,4983,8004,0184,3484,3294,3884,3891,8180001,362
       Long-term Assets Other 
0
0
0
0
3,039
3,486
1,406
1,481
1,700
1,874
2,271
2,403
1,822
2,178
2,379
2,778
3,448
4,198
5,098
6,159
8,458
10,566
12,146
4,903
5,245
5,2454,90312,14610,5668,4586,1595,0984,1983,4482,7782,3792,1781,8222,4032,2711,8741,7001,4811,4063,4863,0390000
> Total Liabilities 
24,744
0
0
0
151,452
20,886
21,687
20,735
16,996
47,469
47,576
60,508
65,692
81,751
83,998
110,510
133,538
129,305
134,090
127,674
139,826
185,638
234,073
222,661
224,412
224,412222,661234,073185,638139,826127,674134,090129,305133,538110,51083,99881,75165,69260,50847,57647,46916,99620,73521,68720,886151,45200024,744
   > Total Current Liabilities 
9,451
0
0
0
8,929
8,419
9,440
8,835
8,821
16,197
16,978
17,047
23,129
20,806
23,273
30,177
36,238
35,414
41,341
41,552
53,342
52,995
72,266
69,736
69,537
69,53769,73672,26652,99553,34241,55241,34135,41436,23830,17723,27320,80623,12917,04716,97816,1978,8218,8359,4408,4198,9290009,451
       Short-term Debt 
0
0
0
0
6,933
584
594
602
640
636
653
684
844
708
773
826
2,383
2,996
2,905
2,811
3,125
4,655
4,680
4,661
4,876
4,8764,6614,6804,6553,1252,8112,9052,9962,3838267737088446846536366406025945846,9330000
       Short Long Term Debt 
0
0
0
0
0
584
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000058400000
       Accounts payable 
2,065
0
0
0
1,887
2,241
2,569
1,992
1,949
4,434
3,338
2,056
1,365
996
3,471
1,761
2,721
3,999
4,859
7,057
6,472
2,813
5,250
8,493
13,050
13,0508,4935,2502,8136,4727,0574,8593,9992,7211,7613,4719961,3652,0563,3384,4341,9491,9922,5692,2411,8870002,065
       Other Current Liabilities 
4,223
0
0
0
99
5,570
5,265
5,433
5,504
5,080
7,568
7,114
10,785
9,008
10,290
10,127
11,861
9,269
14,047
15,280
23,327
20,557
32,582
29,392
26,633
26,63329,39232,58220,55723,32715,28014,0479,26911,86110,12710,2909,00810,7857,1147,5685,0805,5045,4335,2655,570990004,223
   > Long-term Liabilities 
0
0
0
0
142,523
12,467
12,247
11,900
8,175
31,272
30,598
43,461
42,563
60,945
60,725
80,333
97,300
93,891
92,749
86,122
86,484
132,643
161,807
152,925
154,875
154,875152,925161,807132,64386,48486,12292,74993,89197,30080,33360,72560,94542,56343,46130,59831,2728,17511,90012,24712,467142,5230000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-6,933
1,837
1,628
1,416
1,251
1,056
850
645
426
3,025
2,801
2,495
12,081
14,093
12,496
10,997
10,885
14,394
11,881
10,423
9,382
9,38210,42311,88114,39410,88510,99712,49614,09312,0812,4952,8013,0254266458501,0561,2511,4161,6281,837-6,9330000
       Long-term Liabilities Other 
0
0
0
0
0
1,050
1,261
1,429
1,995
2,010
2,085
2,307
2,611
2,806
2,961
3,041
3,279
3,362
3,260
3,157
3,829
4,081
4,330
4,316
4,579
4,5794,3164,3304,0813,8293,1573,2603,3623,2793,0412,9612,8062,6112,3072,0852,0101,9951,4291,2611,05000000
       Deferred Long Term Liability 
0
0
0
0
1,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000001,6000000
> Total Stockholder Equity
-47,184
-47,184
0
0
-69,826
56,915
104,559
95,325
93,198
81,813
71,026
109,551
95,460
142,091
142,050
170,823
346,254
330,258
311,392
289,474
270,783
243,163
220,097
416,022
370,932
370,932416,022220,097243,163270,783289,474311,392330,258346,254170,823142,050142,09195,460109,55171,02681,81393,19895,325104,55956,915-69,82600-47,184-47,184
   Common Stock
4
0
0
0
10
173
226
226
227
227
228
264
266
300
309
329
384
385
385
385
387
389
396
550
550
550550396389387385385385384329309300266264228227227226226173100004
   Retained Earnings -511,760-462,661-412,763-370,160-331,096-301,118-272,771-245,943-218,379-200,342-185,664-167,751-151,560-134,127-123,989-111,874-100,550-96,144-86,662-76,445-69,942000-48,096
   Capital Surplus 
0
0
0
0
1,857
2,132
193,178
193,850
195,056
197,179
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000197,179195,056193,850193,1782,1321,8570000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
69
0
0
0
1,857
133,858
193,178
193,850
195,056
197,179
198,507
246,391
249,947
312,793
330,911
374,029
567,637
578,284
584,152
589,679
601,105
612,863
633,341
875,248
883,446
883,446875,248633,341612,863601,105589,679584,152578,284567,637374,029330,911312,793249,947246,391198,507197,179195,056193,850193,178133,8581,85700069



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue26,976
Cost of Revenue-6,571
Gross Profit20,40520,405
 
Operating Income (+$)
Gross Profit20,405
Operating Expense-216,328
Operating Income-189,946-195,923
 
Operating Expense (+$)
Research Development156,496
Selling General Administrative59,832
Selling And Marketing Expenses0
Operating Expense216,328216,328
 
Net Interest Income (+$)
Interest Income14,002
Interest Expense-3,263
Other Finance Cost-0
Net Interest Income10,739
 
Pretax Income (+$)
Operating Income-189,946
Net Interest Income10,739
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-179,207-189,352
EBIT - interestExpense = -178,613
-179,207
-177,401
Interest Expense3,263
Earnings Before Interest and Taxes (EBIT)-175,350-175,944
Earnings Before Interest and Taxes (EBITDA)-168,804
 
After tax Income (+$)
Income Before Tax-179,207
Tax Provision-1,457
Net Income From Continuing Ops-180,664-180,664
Net Income-180,664
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses216,328
Total Other Income/Expenses Net-594-10,739
 

Technical Analysis of Bicycle Therapeutics Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bicycle Therapeutics Ltd. The general trend of Bicycle Therapeutics Ltd is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bicycle Therapeutics Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bicycle Therapeutics Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 27.24 < 27.50 < 28.91.

The bearish price targets are: 23.55 > 22.66 > 22.49.

Tweet this
Bicycle Therapeutics Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bicycle Therapeutics Ltd. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bicycle Therapeutics Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bicycle Therapeutics Ltd. The current macd is 0.76311299.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bicycle Therapeutics Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Bicycle Therapeutics Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Bicycle Therapeutics Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Bicycle Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBicycle Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bicycle Therapeutics Ltd. The current adx is 21.46.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bicycle Therapeutics Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Bicycle Therapeutics Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bicycle Therapeutics Ltd. The current sar is 23.07.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Bicycle Therapeutics Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bicycle Therapeutics Ltd. The current rsi is 53.51. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Bicycle Therapeutics Ltd Daily Relative Strength Index (RSI) ChartBicycle Therapeutics Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bicycle Therapeutics Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bicycle Therapeutics Ltd price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Bicycle Therapeutics Ltd Daily Stochastic Oscillator ChartBicycle Therapeutics Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bicycle Therapeutics Ltd. The current cci is -38.13860493.

Bicycle Therapeutics Ltd Daily Commodity Channel Index (CCI) ChartBicycle Therapeutics Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bicycle Therapeutics Ltd. The current cmo is -1.33784961.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bicycle Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) ChartBicycle Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bicycle Therapeutics Ltd. The current willr is -41.93566528.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Bicycle Therapeutics Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Bicycle Therapeutics Ltd Daily Williams %R ChartBicycle Therapeutics Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bicycle Therapeutics Ltd.

Bicycle Therapeutics Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bicycle Therapeutics Ltd. The current atr is 1.38910986.

Bicycle Therapeutics Ltd Daily Average True Range (ATR) ChartBicycle Therapeutics Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bicycle Therapeutics Ltd. The current obv is 2,637,566.

Bicycle Therapeutics Ltd Daily On-Balance Volume (OBV) ChartBicycle Therapeutics Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bicycle Therapeutics Ltd. The current mfi is 52.12.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Bicycle Therapeutics Ltd Daily Money Flow Index (MFI) ChartBicycle Therapeutics Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bicycle Therapeutics Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Bicycle Therapeutics Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bicycle Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.513
Ma 20Greater thanMa 5024.817
Ma 50Greater thanMa 10021.774
Ma 100Greater thanMa 20018.922
OpenGreater thanClose24.660
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bicycle Therapeutics Ltd with someone you think should read this too:
  • Are you bullish or bearish on Bicycle Therapeutics Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bicycle Therapeutics Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bicycle Therapeutics Ltd

I send you an email if I find something interesting about Bicycle Therapeutics Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Bicycle Therapeutics Ltd.

Receive notifications about Bicycle Therapeutics Ltd in your mailbox!